DelveInsight’s Acute Respiratory Distress Syndrome - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Acute Respiratory Distress Syndrome for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Acute Respiratory Distress Syndrome forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Acute Respiratory Distress Syndrome till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Acute Respiratory Distress Syndrome market.
• Identifying patient populations in the global “Acute Respiratory Distress Syndromemarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Acute Respiratory Distress Syndrome therapeutics in each of the markets covered.
• To understand the future market competition in the global Acute Respiratory Distress Syndrome therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Acute Respiratory Distress Syndrome for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
Note: This report requires 7-10 business days to complete.
'
Table of Contents
• Acute Respiratory Distress Syndrome overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Acute Respiratory Distress Syndrome Market
• Global Epidemiology of Acute Respiratory Distress Syndrome Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Acute Respiratory Distress Syndrome Drug Sales (USD Millions)
• Table 6: Global Epidemiology of Acute Respiratory Distress Syndrome(2013-2023)
• Table 7: Acute Respiratory Distress Syndrome Global Market (USD Millions), (2013-2015)
• Table 8: Acute Respiratory Distress Syndrome Global Market (USD Millions), (2016-2023)
• Table 9: Acute Respiratory Distress Syndrome US Market (USD Millions), (2013-2015)
• Table 10: Acute Respiratory Distress Syndrome US Market (USD Millions), (2016-2023)
• Table 11: Acute Respiratory Distress Syndrome Germany Market (USD Millions), (2013-2015)
• Table 12: Acute Respiratory Distress Syndrome Germany Market (USD Millions), (2016-2023)
• Table 13: Acute Respiratory Distress Syndrome United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Acute Respiratory Distress Syndrome United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Acute Respiratory Distress Syndrome France Market (USD Millions), (2013-2015)
• Table 16: Acute Respiratory Distress Syndrome France Market (USD Millions), (2016-2023)
• Table 17: Acute Respiratory Distress Syndrome Italy Market (USD Millions), (2013-2015)
• Table 18: Acute Respiratory Distress Syndrome Italy Market (USD Millions), (2016-2023)
• Table 19: Acute Respiratory Distress Syndrome Spain Market (USD Millions), (2013-2015)
• Table 20: Acute Respiratory Distress Syndrome Spain Market (USD Millions), (2016-2023)
• Table 21: Acute Respiratory Distress Syndrome Japan Market (USD Millions), (2013-2015)
• Table 22: Acute Respiratory Distress Syndrome Japan Market (USD Millions), (2016-2023)
• Table 23: Acute Respiratory Distress Syndrome ROW Market (USD Millions), (2013-2015)
• Table 24: Acute Respiratory Distress Syndrome ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Acute Respiratory Distress Syndrome Drug Sales (USD Millions)
• Figure 2: Global Epidemiology of Acute Respiratory Distress Syndrome (2013-2023)
• Figure 3: Acute Respiratory Distress Syndrome Global Market (USD Millions), (2013-2015)
• Figure 4: Acute Respiratory Distress Syndrome Global Market (USD Millions), (2016-2023)
• Figure 5: Acute Respiratory Distress Syndrome US Market (USD Millions), (2013-2015)
• Figure 6: Acute Respiratory Distress Syndrome US Market (USD Millions), (2016-2023)
• Figure 7: Acute Respiratory Distress Syndrome Germany Market (USD Millions), (2013-2015)
• Figure 8: Acute Respiratory Distress Syndrome Germany Market (USD Millions), (2016-2023)
• Figure 9: Acute Respiratory Distress Syndrome United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Acute Respiratory Distress Syndrome United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Acute Respiratory Distress Syndrome France Market (USD Millions), (2013-2015)
• Figure 12: Acute Respiratory Distress Syndrome France Market (USD Millions), (2016-2023)
• Figure 13: Acute Respiratory Distress Syndrome Italy Market (USD Millions), (2013-2015)
• Figure 14: Acute Respiratory Distress Syndrome Italy Market (USD Millions), (2016-2023)
• Figure 15: Acute Respiratory Distress Syndrome Spain Market (USD Millions), (2013-2015)
• Figure 16: Acute Respiratory Distress Syndrome Spain Market (USD Millions), (2016-2023)
• Figure 17: Acute Respiratory Distress Syndrome Japan Market (USD Millions), (2013-2015)
• Figure 18: Acute Respiratory Distress Syndrome Japan Market (USD Millions), (2015-2023)
• Figure 19: Acute Respiratory Distress Syndrome ROW Market (USD Millions), (2013-2015)
• Figure 20: Acute Respiratory Distress Syndrome ROW Market (USD Millions), (2016-2023)
• GlaxoSmithKline
• Altor BioScience Corporation
• mondoBIOTECH
• Alliance Pharmaceutical Corporation
• BioLineRx
• Asubio Pharma
• AbbVie
• Pfizer
• Amgen
